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doi:10.1016/j.ijid.2007.04.003Figure 1 CT scan showing the mass at presentation.Tuberculosis of the pancreas mimicking carci-
noma
The HIV/AIDS pandemic has affected the South African popu-
lation more than most. Tuberculosis (TB) is endemic in South
Africa and this has been severely aggravated by the advent of
AIDS.1,2 Tuberculosis presents in many guises, some common,
some extremely rare. Often, it is only a high index of suspi-
cion that helps make the diagnosis. We present herein a
patient who presented with obstructive jaundice and a mass
in the head of the pancreas, which resolved on anti-TB
treatment, to serve as a caveat to others.
A 33-year-old female was referred to the surgery depart-
ment of the Pretoria Academic Hospital. She complained of
pain in the right hypochondrium, which had been present for
two weeks. The pain was constant and not affected by meals.
She described her stools as being green in color. The patient
weighed 75 kg, which was her approximate expected weight
for height. She was jaundiced. None of the typical constitu-
tional symptoms of tuberculosis were reported on question-
ing, nor was the patient observed to have fever, nausea,
vomiting or night sweats during her hospital stay. There was
nomedical or surgical history of any note. The patient did not
have any known TB contacts. The patient had oral candidia-
sis. There was a 3 cm mass in her left supraclavicular fossa
fixed to underlying structures. A vague epigastric mass was
felt on clinical examination, which was otherwise unremark-
able — the liver appeared to be of normal size and the
gallbladder was not clinically palpable. Vital signs were
normal throughout her hospital stay.
On admission, the patient’s full blood count was normal,
the liver functions were typical of obstructive jaundice
(bilirubin 117.3 mmol/l, ALP 401 IU/l, gGT 462 IU/l, ALT
64 IU/L, AST 57 IU/L), and the CRP was 90 mg/l. Chest
X-ray was normal. Due to the endemic nature of tuberculosis
in South Africa, a purified protein derivative (PPD) skin test
was not performed. Pancreatic enzymes were not tested.
Serum albumin was 24 g/l on admission.
Abdominal ultrasound showed a large cystic mass in the
head of the pancreas. Intra- and extra-hepatic bile ducts
were dilated. A computed tomography (CT) scan confirmed
the presence of a 4.47  3.37  4.4 cm cystic mass in the
head of the pancreas (Figure 1). The mass was thick-walled
with septae. There was no sign of intra-abdominal lym-
phadenopathy. In consultation with the radiologists, a
preliminary diagnosis of a periampullary carcinoma was
made.Fine needle aspiration (FNA) of the supraclavicular
lymph node was performed. This yielded copious numbers
of TB bacilli. The patient also tested positive for HIV, with a
CD4 count of 164. A thorough examination showed no other
sites of tuberculous involvement. Due to the patient’s
general condition, as well as the diagnosis of tuberculosis
based on the supraclavicular lymph node, a CT-guided FNA
of the mass in the pancreas was not attempted. It was
considered possible that the mass in the pancreas was due
to TB.
The patient was started on anti-TB treatment with a
standard regimen of rifampin, isoniazid and pyrazinamide.
She was also referred for antiretroviral therapy. Rapid
improvement of symptoms and resolution of the jaundice
followed within a period of several days, as demonstrated by
the rapid normalization of liver function tests (Table 1). The
CT scan was repeated a month later and showed that the
maximal diameter of the cystic mass had decreased to
3.71 cm and the bile ducts were no longer dilated
(Figure 2). Treatment for TB, as well as highly active anti-
retroviral therapy (HAART) was continued. Liver functions
had normalized at the one-year follow-up.
In a landmark study in 1941, Auerbach reported on 1656
autopsies on patients with TB.3 Of these, 297 had miliary TB
(18%) and only 14 of the 297 cases had any evidence of
pancreatic involvement (4.7%). In 1977 Bhansali reported
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Table 1 Sequential biochemical markers
Date Total bilirubin
(N = 0—21 mmol/l)
ALP
(N = 40—120 IU/l)
gGT
(N = 0—35 IU/l)
ALT
(N = 5—40 IU/l)
AST
(N = 5—40 IU/l)
Admission 117.3 401 462 64 57
1 week 54.8 310 217 42 47
8 weeks 13.0 99 147 315 211
3 months 12.6 85 84 31 29
1 year 10.0 81 37 29 22on 300 cases of abdominal TB. There were no cases of
pancreatic TB.4 Pancreatic involvement in TB is extremely
rare. This is thought to be due to the anti-tuberculous effect
of pancreatic enzymes.5
Many case reports have been published, but very few
studies of pancreatic TB have been made. Several authors
have collectively reviewed these case reports. Some authors
have suggested diagnostic protocols.6 However, due to the
paucity of cases, no consensus has been achieved. The
HIV/AIDS pandemic may very well occasion larger clinical
studies and lead to accepted protocols.
Due to the rarity of a tuberculous mass in the head of the
pancreas, and the fact that both clinically and radiologically
it mimics a periampullary carcinoma,7—9 these patients are
often diagnosed at laparotomy. The presence of tuberculous
cervical lymphadenopathy in our case obviated this.
The mechanism of spread of tubercle bacilli to the pan-
creas is uncertain. It is speculated that this is either through
hematogenous spread from an occult lesion in the lung or
abdomen, or via direct spread from contiguous lymph nodes.
A third theory is that dormant bacilli in an old lesion can be
reactivated during an immunosuppressed state.10
Clinical features of pancreatic TB are non-specific. In
a meta-analysis of 12 published reports, Lo et al. listed
constitutional symptoms (weight loss, fever, malaise, nightFigure 2 CT scan two weeks after commencement of therapy.sweats), epigastric pain, nausea, vomiting, diarrhea, right
upper quadrant pain and obstructive jaundice as the
most common presenting manifestations.11 Most of the cases
analyzed by them had no extra-pancreatic tuberculous
lesions.
Biochemistry and hematology are usually not helpful in
making the diagnosis. In our case the diagnosis of obstructive
jaundice was not specific.
The initial diagnosis of a pancreas mass has often been
made on abdominal sonar. This mass has been described as
being solid, cystic, low density, hypo-echoic, calcified, etc.12
In most cases an abdominal CTscan has also been performed,
which has confirmed the presence of a mass.
Pombo et al. retrospectively reviewed the CT scans of six
patients with proven TB of the pancreas.6 They concluded
that in HIV-negative patients there is a non-specific focal
mass lesion, whereas in HIV-positive patients there is a
greater spectrum of findings, including focal mass lesions,
multiple small low-attenuation pancreatic nodules or diffuse
enlargement of the gland. They also listed a number of
ancillary findings to support the diagnosis, including low-
attenuation peripancreatic and periportal lymphadenopa-
thies with peripheral rim-enhancement. The CT scan of our
patient, who was HIV-positive, revealed a rather homogenous
cystic focal lesion in the head of the pancreas.
Various methods have been described to confirm the
diagnosis. In a review of 51 case reports in the literature
by Demir et al., seven were diagnosed by CT-guided FNA and
44 underwent diagnostic laparotomy.7 Several case reports
detail patients who have undergone pancreatico-duodenect-
omy to make the diagnosis.13,14 Trial of therapy may be
indicated in those patients who are at high risk for TB and
where there is evidence of TB elsewhere in the body, as was
done in our patient.
TB of the pancreas is rare. However, one of the great
mimics of the past is experiencing a resurgence in the AIDS
era, and it would be wise to consider the diagnosis of TB even
in such unlikely organs as the pancreas.
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doi:10.1016/j.ijid.2007.04.004Escherichia vulneris as a cause of bacteremia in
a patient with chronic lymphocytic leukemia
Escherichia vulneris is a recently identified environmental
organism that can colonize humans and animals. It has mainly
been recovered from human wounds.1 Very few infections
with E. vulneris have been reported. Pien et al.2 described a
series of 12 Hawaiian patients who had E. vulneris isolated
from soft tissues. It now seems clear that these organisms can
cause invasive infections in immunocompetent and immuno-
depressed patients, as is shown in the following case.
A 70-year-old man, treated two years previously for
chronic lymphocytic leukemia and followed in the Depart-
ment of Hematology, was admitted to the hospital because of
rigors, fever and left gonalgia. He was allergic to beta-
lactams and received no medications as prophylaxis. On
physical examination, his temperature was 39 8C, and there
was a tenderness of the knee, where a subcutaneous mass
was detected with fluctuation. He had a blood pressure of
100/80 mmHg, and the remainder of the examination was
unremarkable. Laboratory examination revealed hemoglobin
of 12.7 g/l, a white blood cell count of 7.8  109/l, and a
platelet count of 335  109/l. Routine blood chemistry and
coagulation tests were normal, except for a C-reactive pro-
tein level of 191 mg/l. Blood cultures yielded Gram-negative
bacilli, identified as E. vulneris by Vitek 1 (bioMerieux).
Susceptibility testing was performed according to the NCCLS
disk diffusion method. The same organism was isolated in the
pus of a subcutaneous abscess after drainage. The organism
was susceptible to ampicillin, cephalosporins, aminoglyco-
sides (gentamicin, amikacin and streptomycin), quinolones
(ciprofloxacin, ofloxacin and levofloxacin) and cotrimoxa-
zole. Surgical debridement was not recommended. The
patient was treated with a combination of ciprofloxacinand gentamicin for one week, and then ciprofloxacin for
seven days. He was discharged on day 15 of treatment, with
almost complete resolution of the soft tissue infection; he
continued the ciprofloxacin treatment for a further 15 days.
At follow-up 2 weeks after completion of treatment, he was
well without any symptoms.
Since 1982, E. vulneris has been classified in the family of
Enterobacteriaceae in Enteric Group 1, on the basis of DNA
relatedness studies and biochemical reactions. It has been
isolated from animals, the environment, potable water and
humans,1,3 where it can colonize many sites, especially
wounds.2 Escherichia vulneris has been identified in many
invasive infections, including osteomyelitis,4 bacteremia,5
urosepsis,6 septic shock7 and meningitis.8 More recently, a
peritonitis in the setting of peritoneal dialysis has been
reported9 in an elderly female patient. Our patient presented
with a colonization of his wound causing a local sepsis, and
because of immunosuppression due to a lymphoproliferative
disorder, bacteremia occurred with the same agent. It is
unclear whether hematologic malignancies, such as myelo-
proliferative or lymphoproliferative disorders, play a role in
the pathogenesis of such infections.
In wounds with E. vulneris infection, co-infection with
other bacteria has been reported, and this may contribute to
the extensive tissue injury seen in such cases.7 Clinical
isolates of E. vulneris are slightly more susceptible to the
commonly used antibiotics than Escherichia coli or Escher-
ichia hermannii, especially aminoglycosides and ticarcillin.10
A reduction in the susceptibility of some strains may suggest a
nosocomial source of the disease.8
In conclusion, to our knowledge, this is the first reported
case of E. vulneris bacteremia in a patient with chronic
lymphocytic leukemia in Tunisia, demonstrating that the
organism is a true pathogen.
